Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The importance of family history in the diagnosis and management of hematological malignancies

V. Koneti Rao • 13 Jun 2022
EHA 2022
General Leukemia Lymphoma

V. Koneti Rao, MD, FRCPA, National Institute of Allergy and Infectious Diseases, Bethesda, MD discusses the importance of taking a patient’s personal and family history to aid in the diagnosis of hematological malignancies. Dr Rao comments on the use of next generation sequencing (NGS)-based gene panel tests and exome sequencing to identify defects in specific genes. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from V. Koneti Rao

2:46
Insights into the pathogenesis and treatment of autoimmune lymphoproliferative syndrome
V. Koneti Rao • 13 Jun 2022
3:29
The pathogenesis and treatment of Evans syndrome
V. Koneti Rao • 13 Jun 2022
2:41
The management of patients with activated PI3K delta syndrome
V. Koneti Rao • 13 Jun 2022
3:55
Phase III study of leniolisib in patients with activated PI3K delta syndrome
V. Koneti Rao • 13 Jun 2022

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals